Logo image of EXA.PA

EXAIL TECHNOLOGIES (EXA.PA) Stock Fundamental Analysis

EPA:EXA - Euronext Paris - Matif - FR0000062671 - Common Stock - Currency: EUR

47.35  +1.95 (+4.3%)

Fundamental Rating

3

Overall EXA gets a fundamental rating of 3 out of 10. We evaluated EXA against 106 industry peers in the Machinery industry. EXA may be in some trouble as it scores bad on both profitability and health. EXA is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year EXA has reported negative net income.
EXA had a positive operating cash flow in the past year.
In multiple years EXA reported negative net income over the last 5 years.
Of the past 5 years EXA 4 years had a positive operating cash flow.
EXA.PA Yearly Net Income VS EBIT VS OCF VS FCFEXA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M 80M

1.2 Ratios

With a Return On Assets value of -0.44%, EXA is not doing good in the industry: 68.87% of the companies in the same industry are doing better.
EXA has a worse Return On Equity (-3.04%) than 72.64% of its industry peers.
EXA's Return On Invested Capital of 2.85% is on the low side compared to the rest of the industry. EXA is outperformed by 66.98% of its industry peers.
EXA had an Average Return On Invested Capital over the past 3 years of 2.19%. This is significantly below the industry average of 8.60%.
The 3 year average ROIC (2.19%) for EXA is below the current ROIC(2.85%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.44%
ROE -3.04%
ROIC 2.85%
ROA(3y)0.31%
ROA(5y)2.54%
ROE(3y)1.41%
ROE(5y)15.21%
ROIC(3y)2.19%
ROIC(5y)2.9%
EXA.PA Yearly ROA, ROE, ROICEXA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1.3 Margins

The Operating Margin of EXA (6.05%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of EXA has grown nicely.
EXA has a Gross Margin of 55.36%. This is in the better half of the industry: EXA outperforms 77.36% of its industry peers.
EXA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.05%
PM (TTM) N/A
GM 55.36%
OM growth 3Y-17.32%
OM growth 5Y16.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.59%
GM growth 5Y2.77%
EXA.PA Yearly Profit, Operating, Gross MarginsEXA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EXA is destroying value.
The number of shares outstanding for EXA has been reduced compared to 1 year ago.
Compared to 5 years ago, EXA has more shares outstanding
The debt/assets ratio for EXA is higher compared to a year ago.
EXA.PA Yearly Shares OutstandingEXA.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
EXA.PA Yearly Total Debt VS Total AssetsEXA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

EXA has an Altman-Z score of 1.49. This is a bad value and indicates that EXA is not financially healthy and even has some risk of bankruptcy.
EXA has a Altman-Z score of 1.49. This is in the lower half of the industry: EXA underperforms 61.32% of its industry peers.
The Debt to FCF ratio of EXA is 6.15, which is on the high side as it means it would take EXA, 6.15 years of fcf income to pay off all of its debts.
EXA has a Debt to FCF ratio (6.15) which is in line with its industry peers.
A Debt/Equity ratio of 2.52 is on the high side and indicates that EXA has dependencies on debt financing.
EXA's Debt to Equity ratio of 2.52 is on the low side compared to the rest of the industry. EXA is outperformed by 89.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.52
Debt/FCF 6.15
Altman-Z 1.49
ROIC/WACC0.43
WACC6.71%
EXA.PA Yearly LT Debt VS Equity VS FCFEXA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

EXA has a Current Ratio of 1.25. This is a normal value and indicates that EXA is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.25, EXA is doing worse than 71.70% of the companies in the same industry.
A Quick Ratio of 0.93 indicates that EXA may have some problems paying its short term obligations.
EXA has a Quick ratio of 0.93. This is comparable to the rest of the industry: EXA outperforms 43.40% of its industry peers.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 0.93
EXA.PA Yearly Current Assets VS Current LiabilitesEXA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

4

3. Growth

3.1 Past

EXA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -128.05%.
EXA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.32%.
The Revenue has been growing slightly by 6.32% on average over the past years.
EPS 1Y (TTM)-128.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.66%
Revenue 1Y (TTM)15.32%
Revenue growth 3Y47.65%
Revenue growth 5Y6.32%
Sales Q2Q%24.34%

3.2 Future

Based on estimates for the next years, EXA will show a very strong growth in Earnings Per Share. The EPS will grow by 88.61% on average per year.
The Revenue is expected to grow by 7.06% on average over the next years.
EPS Next Y1276.91%
EPS Next 2Y447.16%
EPS Next 3Y235.58%
EPS Next 5Y88.61%
Revenue Next Year19.58%
Revenue Next 2Y21.56%
Revenue Next 3Y18.65%
Revenue Next 5Y7.06%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
EXA.PA Yearly Revenue VS EstimatesEXA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
EXA.PA Yearly EPS VS EstimatesEXA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 1 1.5 2

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EXA. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 53.76, the valuation of EXA can be described as expensive.
EXA's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. EXA is more expensive than 73.58% of the companies in the same industry.
EXA's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 20.77.
Industry RankSector Rank
PE N/A
Fwd PE 53.76
EXA.PA Price Earnings VS Forward Price EarningsEXA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100 -150 -200

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of EXA indicates a somewhat cheap valuation: EXA is cheaper than 65.09% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 14.55
EV/EBITDA N/A
EXA.PA Per share dataEXA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

EXA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as EXA's earnings are expected to grow with 235.58% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y447.16%
EPS Next 3Y235.58%

0

5. Dividend

5.1 Amount

EXA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

EXAIL TECHNOLOGIES

EPA:EXA (4/30/2025, 7:00:00 PM)

47.35

+1.95 (+4.3%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)03-25 2025-03-25/amc
Earnings (Next)07-23 2025-07-23
Inst Owners20.98%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap824.84M
Analysts82.86
Price Target45.67 (-3.55%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.02
Dividend Growth(5Y)-41.67%
DP-10.05%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)68.96%
PT rev (3m)86.56%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-9.64%
EPS NY rev (3m)29.51%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.32%
Revenue NY rev (3m)-1.84%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 53.76
P/S 2.21
P/FCF 14.55
P/OCF 9.02
P/B 6.88
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.21
EYN/A
EPS(NY)0.88
Fwd EY1.86%
FCF(TTM)3.25
FCFY6.87%
OCF(TTM)5.25
OCFY11.08%
SpS21.42
BVpS6.88
TBVpS-17.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.44%
ROE -3.04%
ROCE 3.88%
ROIC 2.85%
ROICexc 3.14%
ROICexgc 14.88%
OM 6.05%
PM (TTM) N/A
GM 55.36%
FCFM 15.2%
ROA(3y)0.31%
ROA(5y)2.54%
ROE(3y)1.41%
ROE(5y)15.21%
ROIC(3y)2.19%
ROIC(5y)2.9%
ROICexc(3y)2.4%
ROICexc(5y)3.68%
ROICexgc(3y)9.45%
ROICexgc(5y)12.41%
ROCE(3y)2.98%
ROCE(5y)3.95%
ROICexcg growth 3Y18.91%
ROICexcg growth 5Y18.06%
ROICexc growth 3Y-17.84%
ROICexc growth 5Y1.29%
OM growth 3Y-17.32%
OM growth 5Y16.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.59%
GM growth 5Y2.77%
F-Score5
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 2.52
Debt/FCF 6.15
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 9.3%
Interest Coverage 1.55
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.25
Quick Ratio 0.93
Altman-Z 1.49
F-Score5
WACC6.71%
ROIC/WACC0.43
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)9.56%
Cap/Sales(5y)12.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-128.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.66%
EPS Next Y1276.91%
EPS Next 2Y447.16%
EPS Next 3Y235.58%
EPS Next 5Y88.61%
Revenue 1Y (TTM)15.32%
Revenue growth 3Y47.65%
Revenue growth 5Y6.32%
Sales Q2Q%24.34%
Revenue Next Year19.58%
Revenue Next 2Y21.56%
Revenue Next 3Y18.65%
Revenue Next 5Y7.06%
EBIT growth 1Y1338.9%
EBIT growth 3Y22.08%
EBIT growth 5Y23.35%
EBIT Next Year188.15%
EBIT Next 3Y61.04%
EBIT Next 5Y29.88%
FCF growth 1Y137.85%
FCF growth 3YN/A
FCF growth 5Y40.49%
OCF growth 1Y64.25%
OCF growth 3YN/A
OCF growth 5Y26.69%